Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Please read the announcement in PDF Attachment 2025_29_Share_buyback_program ...
-
Please read the announcement in PDF Attachment 2025_28_Trading_By_Management ...
-
Novonesis has successfully completed the acquisition of dsm-firmenich’s share of the Feed Enzyme Alliance following the satisfaction of all closing conditions. The acquisition was initially announced...
-
Please read the announcement in PDF Attachment 2025_27_Share_buyback_program ...
-
Please read the announcement in PDF Attachment 2025_26_Share_buyback_program ...
-
As a next step on Novonesis’ integration journey, we combine the two EVP areas Human Health Biosolutions and Strategy & Integration. COPENHAGEN, Denmark – After successfully combining into one...
-
Please read the announcement in PDF Attachment 2025_25_Share_buyback_program ...
-
Please read the announcement in PDF Attachment 2025_24_Share_buyback_program ...
-
Please read the announcement in PDF Attachment 2025_23_Trading_By_Management ...
-
COPENHAGEN, Denmark – May 8, 2025. The global leader in biosolutions, Novonesis, had a strong start to its financial year with organic sales growth of 11% and an adjusted EBITDA margin of 38.3%. The...